163 related articles for article (PubMed ID: 9269965)
1. Mutation analysis of p53 gene in childhood malignant solid tumors.
Kusafuka T; Fukuzawa M; Oue T; Komoto Y; Yoneda A; Okada A
J Pediatr Surg; 1997 Aug; 32(8):1175-80. PubMed ID: 9269965
[TBL] [Abstract][Full Text] [Related]
2. Mutations of p53 in Wilms' tumors.
Takeuchi S; Bartram CR; Ludwig R; Royer-Pokora B; Schneider S; Imamura J; Koeffler HP
Mod Pathol; 1995 Jun; 8(5):483-7. PubMed ID: 7675765
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the p53 gene by PCR-SSCP in ten cases of Wilms' tumor.
Defavery R; Lemos JA; Kashima S; Bernardes JE; Scridelli CA; Covas DT; Tone LG
Sao Paulo Med J; 2000 Mar; 118(2):49-52. PubMed ID: 10772697
[TBL] [Abstract][Full Text] [Related]
4. Mutations of the p53 tumor suppressor gene occur infrequently in Wilms' tumor.
Malkin D; Sexsmith E; Yeger H; Williams BR; Coppes MJ
Cancer Res; 1994 Apr; 54(8):2077-9. PubMed ID: 8174107
[TBL] [Abstract][Full Text] [Related]
5. Frequent occurrence of p53 mutations in rhabdomyosarcoma and leiomyosarcoma, but not in fibrosarcoma and malignant neural tumors.
Würl P; Taubert H; Bache M; Kroll J; Meye A; Berger D; Siermann A; Holzhausen HJ; Hinze R; Schmidt H; Rath FW
Int J Cancer; 1996 Aug; 69(4):317-23. PubMed ID: 8797875
[TBL] [Abstract][Full Text] [Related]
6. Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas.
Komuro H; Hayashi Y; Kawamura M; Hayashi K; Kaneko Y; Kamoshita S; Hanada R; Yamamoto K; Hongo T; Yamada M
Cancer Res; 1993 Nov; 53(21):5284-8. PubMed ID: 8221663
[TBL] [Abstract][Full Text] [Related]
7. A mutational hot spot in the p53 gene is associated with hepatoblastomas.
Oda H; Nakatsuru Y; Imai Y; Sugimura H; Ishikawa T
Int J Cancer; 1995 Mar; 60(6):786-90. PubMed ID: 7896446
[TBL] [Abstract][Full Text] [Related]
8. Mutation of the p53 gene in neuroblastoma and its relationship with N-myc amplification.
Imamura J; Bartram CR; Berthold F; Harms D; Nakamura H; Koeffler HP
Cancer Res; 1993 Sep; 53(17):4053-8. PubMed ID: 8358734
[TBL] [Abstract][Full Text] [Related]
9. Infrequent p53 gene mutations and lack of p53 protein expression in clear cell sarcoma of the kidney: immunohistochemical study and mutation analysis of p53 in renal tumors of unfavorable prognosis.
Hsueh C; Wang H; Gonzalez-Crussi F; Lin JN; Hung IJ; Yang CP; Jiang TH
Mod Pathol; 2002 Jun; 15(6):606-10. PubMed ID: 12065773
[TBL] [Abstract][Full Text] [Related]
10. Infrequent mutations of the TP53 gene and no amplification of the MDM2 gene in hepatoblastomas.
Ohnishi H; Kawamura M; Hanada R; Kaneko Y; Tsunoda Y; Hongo T; Bessho F; Yokomori K; Hayashi Y
Genes Chromosomes Cancer; 1996 Mar; 15(3):187-90. PubMed ID: 8721685
[TBL] [Abstract][Full Text] [Related]
11. P53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India.
Katiyar S; Dash BC; Thakur V; Guptan RC; Sarin SK; Das BC
Cancer; 2000 Apr; 88(7):1565-73. PubMed ID: 10738214
[TBL] [Abstract][Full Text] [Related]
12. Lack of p53 point mutations in chemically induced mouse hepatoblastomas: an end-stage, highly malignant hepatocellular tumor.
Calvert RJ; Tashiro Y; Buzard GS; Diwan BA; Weghorst CM
Cancer Lett; 1995 Aug; 95(1-2):175-80. PubMed ID: 7656227
[TBL] [Abstract][Full Text] [Related]
13. Absence of p53 gene mutation and infrequent overexpression of p53 protein in hepatoblastoma.
Chen TC; Hsieh LL; Kuo TT
J Pathol; 1995 Jul; 176(3):243-7. PubMed ID: 7674087
[TBL] [Abstract][Full Text] [Related]
14. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.
Hietanen SH; Kurvinen K; Syrjänen K; Grénman S; Carey T; McClatchey K; Syrjänen S
Am J Obstet Gynecol; 1995 Nov; 173(5):1477-82. PubMed ID: 7503188
[TBL] [Abstract][Full Text] [Related]
15. Mutation of the p53 gene in postradiation sarcoma.
Nakanishi H; Tomita Y; Myoui A; Yoshikawa H; Sakai K; Kato Y; Ochi T; Aozasa K
Lab Invest; 1998 Jun; 78(6):727-33. PubMed ID: 9645763
[TBL] [Abstract][Full Text] [Related]
16. Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous system.
Ohgaki H; Eibl RH; Schwab M; Reichel MB; Mariani L; Gehring M; Petersen I; Höll T; Wiestler OD; Kleihues P
Mol Carcinog; 1993; 8(2):74-80. PubMed ID: 8397797
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of the tumor suppressor WTX in a subset of pediatric tumors.
Akhavanfard S; Vargas SO; Han M; Nitta M; Chang CB; Le LP; Fazlollahi L; Nguyen Q; Ma Y; Cosper A; Dias-Santagata D; Han JY; Bergethon K; Borger DR; Ellisen LW; Pomeroy SL; Haber DA; Iafrate AJ; Rivera MN
Genes Chromosomes Cancer; 2014 Jan; 53(1):67-77. PubMed ID: 24249259
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of human Dickkopf-1, an antagonist of wingless/WNT signaling, in human hepatoblastomas and Wilms' tumors.
Wirths O; Waha A; Weggen S; Schirmacher P; Kühne T; Goodyer CG; Albrecht S; Von Schweinitz D; Pietsch T
Lab Invest; 2003 Mar; 83(3):429-34. PubMed ID: 12649343
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of ras and p53 gene mutations in carcinomas in the forestomach and intestine and soft tissue sarcomas induced by N-methyl-N-nitrosourea in the rat.
Matsumoto K; Iwase T; Hirono I; Nishida Y; Iwahori Y; Hori T; Asamoto M; Takasuka N; Kim DJ; Ushijima T; Nagao M; Tsuda H
Jpn J Cancer Res; 1997 Feb; 88(2):129-36. PubMed ID: 9119740
[TBL] [Abstract][Full Text] [Related]
20. Reduced or absent expression and codon 201Gly/Arg polymorphism of DCC gene in rhabdomyosarcoma and Ewing's sarcoma/PNET family.
Choi SH; Kong XT; Taki T; Tsuchida Y; Kawaguchi H; Kato H; Hanada R; Look AT; Hayashi Y
Int J Mol Med; 2000 Oct; 6(4):463-7. PubMed ID: 10998440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]